PROTACs Outperform MDM2 Inhibition in ER+ Cells
In a groundbreaking study published in BMC Cancer, researchers have unveiled the remarkable efficacy of targeting the oncogenic regulator mdm2 ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled the remarkable efficacy of targeting the oncogenic regulator mdm2 ...
Here are a few options, all within 8 words:
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine